Sivik Global Healthcare LLC Acadia Pharmaceuticals Inc Transaction History

Sivik Global Healthcare LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$36.21 - $51.4 $1.45 Million - $2.06 Million	-40,000 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$22.22 - $44.01 $222,200 - $440,100	-10,000 Reduced 20.0%	40,000 $1.44 Million
Q2 2019 Aug 14, 2019	BUY	$23.32 - $28.12 $1.17 Million - $1.41 Million	50,000 New	50,000 $1.34 Million
Q3 2018 Nov 13, 2018	SELL	$13.03 - $21.81 $616,983 - $1.03 Million	-47,351 Closed	0 $0
Q2 2018 Aug 06, 2018	BUY	$15.07 - $22.34 $713,579 - $1.06 Million	47,351 New	47,351 $723,000
Q1 2018 May 08, 2018	SELL	$22.47 - $32.33 $1.46 Million - $2.1 Million	-65,000 Closed	0 $0
Q4 2017 Feb 08, 2018	SELL	$26.84 - $39.14 $1.48 Million - $2.15 Million	-55,000 Reduced 45.83%	65,000 $1.96 Million
Q3 2017 Nov 08, 2017	BUY	$29.49 - $38.37 $3.54 Million - $4.6 Million	120,000	120,000 $4.52 Million

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.68B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Sivik Global Healthcare LLC, based on Form 13F filings with the SEC.

Stay updated on Sivik Global Healthcare LLC with notifications on news.